Viatris VTRS
NASDAQ VTRS
$16.50 -0.11 (-0.66%)
As of: Sep 9, 2026 · 3:59 PM EDT

Viatris (VTRS) Share-based Compensation (2020 - 2026)

Viatris (VTRS) posted Share-based Compensation of $30.4 million for Q2 2026, down 46.19% on a QoQ basis from $56.5 million in Q1 2026, and down 18.06% year-over-year from $37.1 million in Q2 2025.

Analysis

Viatris (VTRS) Share-based Compensation (2020 - 2026) Analysis & Trends

Viatris has reported Share-based Compensation for 7 years, with the latest figure at $30.4 million in Q2 2026.

  • On a quarterly basis, Share-based Compensation fell 18.06% year-over-year to $30.4 million in Q2 2026; TTM through Jun 2026 was $172.3 million, a 9.75% increase from a year earlier, with the FY2025 full-year figure at $177.7 million, up 21.63% from the prior year.
  • Share-based Compensation was $30.4 million for Q2 2026 at Viatris, down from $56.5 million in the prior quarter.
  • The five-year high for Share-based Compensation was $56.5 million in Q1 2026, with the low at $28.3 million in Q1 2022.
  • Average Share-based Compensation over 5 years is $39.3 million, with a median of $36.6 million recorded in 2025.
  • The sharpest annual moves came in 2023 and 2024: Share-based Compensation jumped 88.51% in 2023, then tumbled 42.11% in 2024.
  • Over 5 years, Share-based Compensation stood at $29.6 million in 2022, then surged by 88.51% to $55.8 million in 2023, then slumped by 42.11% to $32.3 million in 2024, then jumped by 52.94% to $49.4 million in 2025, then plunged by 38.46% to $30.4 million in 2026.
  • The last three Share-based Compensation figures came in at $30.4 million (Q2 2026), $56.5 million (Q1 2026), and $49.4 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn 40.00 Mn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn 30.40 Mn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn 1.02 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 176,000.00
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 54.00 Mn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn 2.92 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 11.41 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 29.30 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn 7.04 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 30.40 Mn
Mar 31, 2026 56.50 Mn
Dec 31, 2025 49.40 Mn
Sep 30, 2025 36.00 Mn
Jun 30, 2025 37.10 Mn
Mar 31, 2025 55.20 Mn
Dec 31, 2024 32.30 Mn
Sep 30, 2024 32.40 Mn
Jun 30, 2024 34.70 Mn
Mar 31, 2024 46.70 Mn
Dec 31, 2023 55.80 Mn
Sep 30, 2023 43.10 Mn
Jun 30, 2023 39.20 Mn
Mar 31, 2023 42.60 Mn
Dec 31, 2022 29.60 Mn
Sep 30, 2022 29.10 Mn
Jun 30, 2022 29.40 Mn
Mar 31, 2022 28.30 Mn
Dec 31, 2021 22.50 Mn
Sep 30, 2021 25.00 Mn